Jerusalem Pharmaceuticals Co. Ltd. (PEX: JPH)

Market Cap	48.95M
Revenue (ttm)	26.50M
Net Income (ttm)	2.91M
Shares Out	18.00M
EPS (ttm)	0.16
PE Ratio	16.76
Forward PE	n/a
Dividend	0.07 (2.61%)
Ex-Dividend Date	n/a

Volume	1,100
Open	3.750
Previous Close	3.840
Day's Range	3.750 - 3.830
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 30, 2025

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. It offers range of over-the-counter, prescription pharmaceutical, and nutritional supplements products. The company produces approximately 300 pharmaceutical products in various dosage forms, such as tablets, capsules, sterile injectables, suspensions, syrups, powders, suppositories, ovules, creams, ointments, and ear and nose drops, as well as solutions. It also produces detergent, cos...

• Industry: Pharmaceutical Preparations
• Founded: 1969
• Employees: 523
• Stock Exchange: Palestine Stock Exchange
• Ticker Symbol: JPH

Financial Performance

In 2023, Jerusalem Pharmaceuticals's revenue was $39.65 million, a decrease of -14.06% compared to the previous year's $46.14 million. Earnings were $6.96 million, a decrease of -3.02%.

Financial numbers in USD